¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѺÎÁ¤¸ÆÇÐȸ (¿Â¶óÀÎ) VT (Ventricular Tachycardia) Symposium 2021 : 2021-11-13

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѺÎÁ¤¸ÆÇÐȸ (¿Â¶óÀÎ) VT (Ventricular Tachycardia) Symposium 2021 : 2021-11-13
±³À°ÀÏÀÚ : 2021-11-13
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) VT (Ventricular Tachycardia) Symposium 2021
ÁÖÃÖ±â°ü : ´ëÇѺÎÁ¤¸ÆÇÐȸ
´ã´çÀÚ : ±èÈ¿Á¤
¿¬¶ôó : 02-318-5416  
À̸ÞÀÏ : khrs9@k-hrs.org      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 50ºÐ  
¼¼ºÎ¼ö°­·á : 20,000¿ø      
ºñ°í ÀÇ»ç(Àü¹®ÀÇ, Àü°øÀÇ, ÀüÀÓÀÇ) : 2¸¸¿ø / ±âŸ: 1¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 11-13 ¿Â¶óÀΠ08:50~08:55 Opening Remarks  ÇѼº¿í(°è¸íÀÇ´ë) 
±âŸ 11-13 ¿Â¶óÀΠ08:55~09:00 Congratulatory Remarks  À̹®Çü(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-13 ¿Â¶óÀΠ09:00~09:10 Utilizing ECG(Electrocardiogram) to Stratify SCD(Sudden Cardiac Death) Risk in CHD(Coronary Heart Disease) Patients with LVEF(Left Ventricular Ejection Fraction)&gt35%  Á¶¹Î¼ö(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 11-13 ¿Â¶óÀΠ09:10~09:20 Risk Stratification of SCD(Sudden Cardiac Death) in Post MI(Myocardial Infraction) Patients/Nonischemic CM(Cardiomyopathy) Patients  Á¶¿µÁø(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-13 ¿Â¶óÀΠ09:20~09:30 Sympathetic Neuromodulation for Management of VT(Ventricular Tachycardia)  ±ÇâÈñ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-13 ¿Â¶óÀΠ09:30~09:40 Approach for Diagnosing Idiopathic VF(Ventricular Fibrillation)  ±è¼ºÈ¯(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 11-13 ¿Â¶óÀΠ09:40~09:50 Appropriate Timing of ICD(Implantable Cardioverter Defibrillator) for The Primary Prevention: What's The Optimal Duration of Medications, Including ARNI(Antiotensin Receptor Neprilysin Inhibitor)?  ±èÁÖ¿¬(¼º±Õ°üÀÇ´ë) 
Åä·Ð 11-13 ¿Â¶óÀΠ09:50~10:10 Discussion  () 
±³À°½Ã°£ 11-13 ¿Â¶óÀΠ10:10~10:20 Changing Paradigms in SCD(Sudden Cardiac Death)  À̼ҷÉ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-13 ¿Â¶óÀΠ10:20~10:30 Redefining Sudden Cardiac Death: Insights The San Francisco POST SCD(Sudden Cardiac Death) Study  À±³²½Ä(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 11-13 ¿Â¶óÀΠ10:30~10:40 Racial Differences in SCD(Sudden Cardiac Death) Risk  ¹ÚÇü¼·(°è¸íÀÇ´ë) 
±³À°½Ã°£ 11-13 ¿Â¶óÀΠ10:40~10:50 SCD(Sudden Cardiac Death) in Mitral Valve Prolapse  ³ë½Â¿µ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 11-13 ¿Â¶óÀΠ10:50~11:00 Sudden Death Risk in Patients with PVCs(Premature Ventricular Contraction)  ±èÀ¯¸®(µ¿±¹ÀÇ´ë) 
Åä·Ð 11-13 ¿Â¶óÀΠ11:00~11:20 Discussion  () 
È޽Ġ11-13 ¿Â¶óÀΠ11:20~11:30 Break Time  () 
±³À°½Ã°£ 11-13 ¿Â¶óÀΠ11:30~11:40 What Should be Considered During Implantation, Single vs. Dual Coil, Transvenous vs. Subcutaneous Etc?  ¹ÚÇü¿í(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 11-13 ¿Â¶óÀΠ11:40~11:50 Is The ATP(Adenocine Triphosphate) Necessary for The Device Setting?  ÃÖÀDZÙ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-13 ¿Â¶óÀΠ11:50~12:00 How to Set The ICD(Implantable Cardioverter Defibrillator) Parameters, How to Avoid Unnecessary or Inappropriate Treatment  ÀÌÁöÇö(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-13 ¿Â¶óÀΠ12:00~12:10 How to Manage The VT(Ventricular Tachycardia) or VF(Ventricular Fibrillation) Episodes During Follow Up  ±èÁø¹è(°æÈñÀÇ´ë) 
±³À°½Ã°£ 11-13 ¿Â¶óÀΠ12:10~12:20 How to Manage The VT(Ventricular Tachycardia) Storm, Including The Timing of Catheter Ablation and Sympathetic Blockade  ÀÌ¿µ¼ö(´ë±¸°¡Å縯ÀÇ´ë) 
Åä·Ð 11-13 ¿Â¶óÀΠ12:20~12:40 Discussion  () 
½Ä»ç 11-13 ¿Â¶óÀΠ12:40~13:30 Lunch  () 
±³À°½Ã°£ 11-13 ¿Â¶óÀΠ13:30~13:40 Anatomy/Ablation of LV(Left Ventricular) Outflow Tract PVC(Premature Ventricular Contraction)/VT(Ventricular Tachycardia)  À̱âÈ«(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 11-13 ¿Â¶óÀΠ13:40~13:50 Cardiac Vein Mapping for PVCs(Premature Ventricular Contraction)  ¾öÀç¼±(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-13 ¿Â¶óÀΠ13:50~14:00 Ablation of Focal Intramural VA(Ventricular Arrhythmia)s Targeting The Site of Origin  ÃÖÁ¾ÀÏ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 11-13 ¿Â¶óÀΠ14:00~14:10 ICE(Intracardiac Echocardiography) Imaging for Idiopathic VT(Ventricular Tachycardia)  °ûÇýºó(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 11-13 ¿Â¶óÀΠ14:10~14:20 Improving Outcome of Ablation for Papillary Muscle VT(Ventricular Tachycardia)  ¹Ú¿¹¹Î(°¡ÃµÀÇ´ë) 
Åä·Ð 11-13 ¿Â¶óÀΠ14:20~14:40 Discussion  () 
±³À°½Ã°£ 11-13 ¿Â¶óÀΠ14:40~14:50 Natural History of Arrhythmias After ICD(Implantable Cardioverter Defibrillator) Implant: PARTITA Lessons  ¹Ú»ó¿ø(ºÎõ ¼¼Á¾º´¿ø) 
±³À°½Ã°£ 11-13 ¿Â¶óÀΠ14:50~15:00 Resynchronization with His and LV(Left Ventricular) Pacing  ¹Ú½ÂÁ¤(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 11-13 ¿Â¶óÀΠ15:00~15:10 Should DFT(Defibrillation Threshold) Testing be Required in S-ICD(Subcutaneous Implantable Cardioverter Defibrillator)?  ³²±ÃÁØ(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 11-13 ¿Â¶óÀΠ15:10~15:20 New Leadless ICD(Implantable Cardioverter Defibrillator) Technologies  ±èÅÂÈÆ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-13 ¿Â¶óÀΠ15:20~15:30 Does Recovery of EF(Ejection Fraction) Preclude ICD(Implantable Cardioverter Defibrillator) Generator Replacement?  ¹é¿ë¼ö(ÀÎÇÏÀÇ´ë) 
Åä·Ð 11-13 ¿Â¶óÀΠ15:30~15:50 Discussion  () 
±âŸ 11-13 ¿Â¶óÀΠ15:50~16:00 Closing Remarks  ÇѼº¿í(°è¸íÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѺÎÁ¤¸ÆÇÐȸ (¿Â¶óÀÎ) VT (Ventricular Tachycardia) Symposium 2021 : 2021-11-13""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦13Â÷ ´ëÇÑÈ­ÀåÇ°ÀÇÇÐȸ Çмú´ëȸ : 2021-11-13
´ÙÀ½±Û (¿Â¶óÀÎ)¼ö¿ø½ÃÀÇ»çȸ Á¦7Â÷ ¿Â¶óÀÎÇмú´ëȸ : 2021-11-13
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 23 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 23 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 30 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 27 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 26 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 16 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 7 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 6 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 14 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 11 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 5 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 17 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 9 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 15 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 12 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷